Literature DB >> 184835

Radioimmunoassay of apolipoprotein A-I of rat serum.

M Fainaru, R J Havel, T E Felker.   

Abstract

A double antibody radioimmunoassay technique was developed for quantification of apolipoprotein A-I, the major apoprotein of rat high density lipoprotein. Apo A-I was labeled with 125I by the chloramine-T method. 125I-labeled apo A-I had the same electrophoretic mobility as unlabeled apo A-I and more than 80% of the 125I was precipitated by rabbit anti apo A-I antibodies. The assay is sensitive at the level of 0.5-5 ng, and has intraassay and interassay coefficients of variation of 4.5 and 6.5% respectively. The specificity of the assay was established by competitive displacement of 125I-labeled apo A-I from its antibody by apo A-I and lipoproteins containing apo A-I, but not by rat albumin and other apoproteins. Immunoreactivity of high density lipoprotein and serum was only about 35% of that of their delipidated forms when Veronal buffer was used as a diluent. Inclusion of 5 mM sodium decyl sulfate in the incubation mixture brought out reactivity equivalent to that found after delipidation. Completeness of the reaction was verified by comparison with the amount of apo A-I in chromatographic fractions of the total apoprotein of high density lipoprotein. Content (weight %, mean values +/- S.D.) of immunoassayable apo A-I was: 62.3 +/- 5.9 in high density lipoprotein; 1.7 +/- 0.3 in low density lipoprotein; 0.09 +/- 0.03 in very low density lipoprotein and 25.0 +/- 5.0 in lymp chylomicrons. Concentration in whole serum was 51.4 +/- 8.9 mg/dl and 33.6 +/- 4.1 mg/dl for female and male rats, respectively (p less than 0.002), equivalent to the sex difference in concentration of high density lipoprotein. 95% of the apo A-I in serum was in high density lipoprotein, 5% in proteins of d greater than 1.21 g/ml and less than 1% in lipoproteins of d less than 1.063 g/ml.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184835     DOI: 10.1016/0005-2795(76)90097-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Authors:  S T Kunitake; M R Jarvis; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Rat intestine secretes discoid high density lipoprotein.

Authors:  P H Green; A R Tall; R M Glickman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  The metabolic conversion of very-low-density lipoprotein into low-density lipoprotein by the extrahepatic tissues of the rat.

Authors:  B S Suri; M E Targ; D S Robinson
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

4.  Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

Authors:  J P McVicar; S T Kunitake; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Effect of calcium on absorption of fatty acid by rat jejunum in vitro.

Authors:  D R Saunders; J Sillery
Journal:  Lipids       Date:  1979-08       Impact factor: 1.880

6.  The intestine as a source of apolipoprotein A1.

Authors:  R M Glickman; P H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

7.  Lipoprotein secretion by isolated perfused livers from streptozotocin-diabetic rats.

Authors:  E M Berry; E Ziv; H Bar-On
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

8.  Secretion of lipoprotein-X by perfused livers of rats with cholestasis.

Authors:  T E Felker; R L Hamilton; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Authors:  R J Havel; Y Chao; E E Windler; L Kotite; L S Guo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.